L26/P-042 Independent effect of advancing paternal age on clinical pregnancy outcomes in IVF and ICSI cycles with young maternal age
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von F. Agresta und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does advancing paternal age, analysed continuously, independently influence clinical pregnancy outcomes in IVF and ICSI cycles when maternal age and treatment-related confounders are strictly controlled? Summary answer Advancing paternal age was independently associated with a small but statistically significant reduction in clinical pregnancy odds in both IVF and ICSI cycles. What is known already Advanced paternal age is associated with declining semen quality and increased sperm DNA damage, but its independent contribution to ART outcomes remains difficult to isolate due to confounding maternal age and embryo factors. Study design, size, duration Retrospective cohort study including 2,812 IVF cycles and 2,070 ICSI cycles. Participants/materials, setting, methods Autologous IVF and ICSI cycles were included where the female partner was <35 years to minimise confounding effects of advanced maternal age and isolate the impact of paternal age. All cycles involved single day-5 fresh or vitrified-warmed blastocyst transfer, with genetically tested embryos excluded. Only women who had undergone ≤2 stimulation cycles were included to limit female-factor infertility. Multivariable logistic regression was performed separately for IVF and ICSI. Paternal age was modelled per 1-year increase. Main results and the role of chance In IVF cycles, each 1 year increase in paternal age was associated with reduced odds of pregnancy, corresponding to a reduction of approximately 2.8% per year (adjusted odds ratio of 0.972; 95% CI 0.952 - 0.993; p < 0.009). In ICSI cycles, each 1-year increase in paternal age was independently associated with reduced odds of pregnancy, corresponding to approximately 1.5% per year (adjusted OR 0.985; 95% CI 0.9718 - 0.9979; p < 0.023). Notably, in the ICSI cohort, where treatment is typically indicated for male factor infertility, the observed age effect suggests an additional detrimental impact of paternal age beyond the underlying male factor diagnosis. In contrast, IVF cycles involve couples with presumed normal semen parameters, highlighting that the paternal age effect is independent of male factor infertility. Limitations, reasons for caution Retrospective design and moderate effect sizes warrant cautious interpretation. Additionally, the method of insemination (IVF vs ICSI) was used as a surrogate for male factor infertility in the absence of specific semen analysis results. Wider implications of the findings Paternal age independently influences pregnancy outcomes in ART and should be considered during counselling of couples undergoing IVF and ICSI. The ICSI results, in particular, highlight that advanced paternal age can exert an effect beyond pre-existing male factor infertility. Trial registration number No
Zitieren
APA
Agresta, F., Polyakov, A., Stern, C., & Gardner, D. (2026). L26/P-042 Independent effect of advancing paternal age on clinical pregnancy outcomes in IVF and ICSI cycles with young maternal age. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.378
Vancouver
Agresta F, Polyakov A, Stern C, Gardner D. L26/P-042 Independent effect of advancing paternal age on clinical pregnancy outcomes in IVF and ICSI cycles with young maternal age. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.378
BibTeX
@article{Agresta2026,
author = {Agresta, F. and Polyakov, A. and Stern, C. and Gardner, D.},
title = {L26/P-042 Independent effect of advancing paternal age on clinical pregnancy outcomes in IVF and ICSI cycles with young maternal age},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.378}
}
EUVIMED